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ABSTRACT A fundamental question concerning the de-
velopment of the extracellular matrix is what factors control
the arrangement of collagen fibrils within a tissue and at the
same time allow for the great diversity of geometric forms ex-
hibited by collagen. In this report, we test the possibility that
physical forces within the embryo serve to organize collagen
fibers into regular patterns. In particular, we test the predic-
tion that patterns of stress having this morphogenetic function
are generated by cell traction, the contractile force exerted by
cells to propel themselves. To study the effects of these me-
chanical forces on the extracellular matrix, type I collagen was
fluorescently labeled and injected into developing chicken
wing buds. When the injected limbs were allowed to develop
and then examined histologically, the exogenous collagen was
found incorporated within normal connective tissues of the
wing. The labeled collagen became arranged according to its
site of injection, forming parts of tendons, perichondria, carti-
lages, perineuria, and blood vessels. Since the injected colla-
gen formed a gel within minutes of its injection, the subse-
quent incorporation of this preformed collagen within orga-
nized structures cannot be explained in terms of molecular
self-assembly or other mechanisms occurring during collagen
deposition. These results demonstrate that, within developing
tissues, patterns of forces exist that are capable of physically
rearranging collagen and determining its long-range order.
During embryonic development, collagen somehow be-
comes organized into a wide variety of different spatial pat-
terns whose mechanical properties lend structural support
and give form to vertebrate tissues. Although much is known
about the self-assembly of collagen molecules into fibrils (1,
2), comparatively little is known about how collagen fibrils
become associated together into the diverse supramolecular
arrangements found in the body. We have recently proposed
that the cellular forces responsible for cell locomotion can
have the additional morphogenetic function of organizing
collagen fibers into regular patterns (3-7). Studies on cell
traction have demonstrated that as cells spread on a flexible
substratum (such as collagen or thin sheets of silicone rub-
ber), each cell acts as a compressive element, drawing mate-
rial inward toward itself and stretching material at distances
of hundreds of micrometers beyond itself (3-5). Cells that
are capable of exerting these kinds of strong tractional forces
include fibroblasts (3-5, 8-11), glial cells (5), endothelial
cells (12), and epithelial cells (13, 14). Other cell types such
as transformed fibroblasts (5, 15, 16), chondrocytes (17),
neurons (5), and leukocytes (4) exert relatively weaker trac-
tional forces.
In collagen matrices, the compressive and tensile strains
generated by cell traction bring about a rearrangement of
collagen fibers. This realignment, in turn, affects cell behav-
ior so that positive feedback cycles arise that spontaneously
generate regular arrangements of cells and matrix (5-7). By
controlling such simple factors as the initial cell distribution
or the resistance of the collagen gel to distortion, a number
of different connective tissue structures can be created in
culture, including the pattern of dermal condensations,
which make up the feather tracts of birds and pelage hair of
mammals (6), the tendon and ligament attachments of mus-
cles to long bones (5), and the arrangement of collagen into
capsules or sheets, which cover many organs (5). Insofar as
they have been tested in situ, the existence of these morpho-
genetic effects has been confirmed. During wound healing
(18), in the development of the cardiac cushion of the heart
(19), and during amphibian gastrulation (20), rearrangement
of extracellular fibers has been observed to follow the migra-
tion of cells into the matrix.
To examine how the extracellular matrix becomes orga-
nized within embryos, we have developed a new experimen-
tal approach that is an extension of our earlier studies on the
morphogenetic effects of fibroblast traction. Fluorescein
isothiocyanate (FITC) was covalently coupled to collagen
from rat tail tendons and injected into wing buds of 4-day-old
chicken embryos. The embryos were allowed to develop for
various periods of time and were then examined to deter-
mine whether this exogenous collagen could be reorganized
by cells and become part of functional structures. We find
that the injected collagen rapidly forms a gel that subse-
quently undergoes reorganization and becomes incorporated
into various connective tissues of the limb. These rearrange-
ments are consistent with the effects of cell traction previ-
ously observed in tissue culture.
MATERIALS AND METHODS
Embryo Culture and Injection. The injection of chicken
embryos was more easily accomplished by raising embryos
as shell-less culture (21). Fertile eggs (purchased from A &
M Hatchery, Santa Rosa, CA) were raised in a forced-draft
incubator for 3 days and were then cracked open (as if crack-
ing an egg for frying) into 100 x 25 mm Petri dishes. The
intact embryos were transfered to a 5% C02/95% air incuba-
tor and injected 24 hr later. For better survival during the
initial 24 hr, additional egg white from unfertile eggs was
added to the dishes. Although the rate of development is
slower in shell-less cultures than in ovo, it continues normal-
ly up to the stages used in this study (days 4-9) (22). Embry-
onic age is given according to the standard Hamburger and
Hamilton (23) series, rather than absolute days of develop-
ment. Embryos were injected under a dissecting microscope
by using a Gilmont (Great Neck, NY) micrometer syringe
filled with 20 centistokes of silicone fluid (Sigma) (1 stoke =
Abbreviation: FITC, fluorescein isothiocyanate.
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1 X 10-4 m2/sec). Micropipettes were pulled to a diameter of
20-30 ,um and mounted onto a Narishige three-way micro-
manipulator. Injections were not limited to any one specific
location, although the region between the shoulder and el-
bow was most often chosen.
Preparation of Fluorescent Collagen. Collagen solutions
were prepared from rat tail tendons dissolved in 0.5 M acetic
acid by the method of Elsdale and Bard (24). FITC was cova-
lently coupled to the collagen using standard methods for
fluorescently labeling antibodies (25). The pH of the collagen
solution was raised to 9.5 by dialysis in 0.25 M NaCl/0.05 M
phosphate. FITC at a concentration of 0.08 mg per mg of
protein was added to the collagen solution and mixed over-
night. Unbound FITC was separated from the labeled colla-
gen by gel filtration on a Sephadex G-25 column. After re-
covery from the column, the collagen was dialyzed against a
solution of Dulbecco-Vogt's modified Eagle's medium
(DME medium; GIBCO) diluted to 1/10th normal strength at
pH 4.0. The concentration of collagen in these solutions was
2-3 mg/ml and between 1 and 3.5 mol of FITC was bound to
1 mol of collagen. Bovine serum albumin at a concentration
of 2 mg/ml was also labeled by the same procedure.
To prepare a collagen solution that would form fibrils after
injection, the solution was neutralized and made isotonic by
adding NaOH and 5 x DME medium in the following propor-
tions: 60% FITC-collagen/20% 5x DME medium/10% 0.15
M NaOH/10% H20 or fetal calf serum. The coupling of
FITC to monomeric collagen does not interfere with its pre-
cipitation into a gel. Under phase-contrast optics, the ap-
pearance of these fluorescent collagen matrices is normal,
and when used in cell culture there is no apparent difference
in cell behavior or morphology when compared to unlabeled
gels (6). Before injection, a sample was removed to deter-
mine the gelation time, which, in all cases, occurred within
10 min at 370C.
Histology. The injected wings were dissected from the em-
bryos, fixed, and embedded in paraplast using the cold etha-
nol fixation method of Sainte-Marie (26). All specimens were
sectioned longitudinally at a thickness of 7 Aum, and they
were mounted in glycerol. The tissue sections were exam-
ined under epifluorescence and phase-contrast optics using a
Nikon Optiphot microscope.
RESULTS
At the time of injection on day 4 of development (stage 24 or
25), the wing bud contains a loose undifferentiated mesen-
chyme. The cartilagenous elements are just beginning to
form, and the extracellular matrix is still poorly developed
with only small amounts of type I collagen present (27, 28).
A total of 40 embryos were injected with -1 pul of fluores-
cent collagen. Fluorescent bovine serum albumin was inject-
ed into another 15 embryos as a control to show that soluble
proteins could not be passively trapped in the extracellular
matrix to form geometric arrangements. Unlike collagen,
which remained at the site of injection, fluorescent bovine
serum albumin diffused away quickly, spreading throughout
the entire wing within 2 hr of injection. In contrast, collagen
remained localized at the initial injection site for as long as
the embryos were maintained. Although the pH and ionic
strength of the collagen solution was adjusted to be the same
for each injection, there was variability in how quickly a gel
was formed. The appearance of the collagen immediately af-
ter injection reflected this variability. When the collagen
gelled immediately upon injection, it formed a compact mass
of fluorescent material that was acellular and discontinuous
from the surrounding tissue (Fig. lA). This same appearance
of a cohesive gelled material was observed when collagen
was allowed to precipitate inside the needle before injection.
When the collagen remained in solution for several minutes
after its injection, the label was distributed in an intercalated
FIG. 1. (A) Fluorescent collagen (arrow), which gelled immedi-
ately after its injection into the wing, is shown in this combined dark
field and fluorescence micrograph. The embryo was injected with 1
/l of collagen at stage 24 and was fixed 10 min afterwards. (Bar =
200 gm.) (B) Intercalated distribution of labeled collagen is shown in
this fluorescence micrograph. Serial sections show that the injection
site is spherical. The embryo was injected at stage 25 and was fixed
30 min afterwards. (Bar = 50 A.m.) (C) Injected collagen (arrow-
heads) is located in the dorsal mesenchyme and dermis anterior to
the radius (ra) and forms a cohesive mass that bulges outward, the
epithelium forming a cap over the bulge. No differentiated struc-
tures have formed in the area near the injection site, and no rear-
rangement of the collagen is detectable. Viewed with phase contrast
optics. Embryo developed to stage 30 (6.5 days). (Bar = 100 gm.)
(D) Transverse section through an injection site in the dermis is
shown in this fluorescence micrograph. Compare distribution and
organization of label shown here with that in B; in this case, howev-
er, the injection site was circular rather than spherical. Embryo sur-
vived until stage 29 (6 days). (Bar = 50 tim.)
pattern within the extracellular spaces (Fig. 1B). The net-
work of collagen that formed outlined the boundaries of cells
and was spread over a large area, yet it still had strong fluo-
rescence. In some embryos, a combination of both of these
patterns was observed.
Alterations in the distribution and organization of the in-
jected collagen were observed as early as 24 hr after injec-
tion (beginning on day 5 of development, stage 27) and up to
9 days (stage 35). In most cases, more than one type of tissue
within a given embryo contained labeled collagen. Table 1
summarizes the distribution, pattern of organization, and
Table 1. Distribution and organization of injected collagen
No. of
Tissue type embryos Pattern of distribution
Loose mesenchyme 12 Networks; cohesive mass;
irregular patches
Dermis 9 Networks; cohesive mass




Epiphysis 3 Irregular patches
Tendon 4 Elongated patches;
parallel strands
Blood vessel 4 Strands on surface
Perineurium 4 Strands on surface
Skeletal muscle 2 Irregular patches; fine
strands
Data are from 28 embryos allowed to develop from stage 27 to 35.
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frequency of occurrence of labeled collagen from 28 embry-
os that had developed from stage 27 to 35. In 5 of these em-
bryos, no remodeling of the labeled collagen was observed.
Labeled collagen became incorporated as part of the struc-
ture of normal connective tissues in the remaining 23 embry-
os. No abnormalities in the morphology of tissues containing
the injected collagen were detected.
Much of the developing limb consists of an uncondensed
loosely organized mesenchyme from which differentiated
structures arise. Label was found most frequently in loose
undifferentiated mesenchyme and in the dermis. In the 5 em-
bryos where no remodeling was observed, the injection site
was located in this loose mesenchyme (Fig. 1C). In each of
these cases, the fluorescent collagen formed a cohesive mass
upon injection, which remained acellular and discontinuous
from the surrounding tissue. However, when an intercalated
distribution of label was found in these same tissues, the in-
jected collagen was distributed into a pattern similar to the
distribution of type I collagen found in loose mesenchyme
and dermis in normal development (28) (Fig. ID). As devel-
opment progressed, the effect of growth was to expand the
material contained within the injection site, so that the dif-
fuse networks of label became spread apart with larger
spaces between the strands of label (compare Fig. 1 B and
D). Because the label initially consisted of networks, it was
difficult to assess whether any changes had occurred in their
organization apart from this expansion.
Inside the diaphysis of cartilage, the label also was spread
apart; in addition, the fluorescence was more diffuse and
less intense. Fig. 2A shows a section in which the initial in-
jection site includes two different tissues, the perichondrium
and the cartilage matrix of the humerus. The label in the car-
tilage matrix is diffuse with no preferred orientation, and its
appearance suggests that the initial network has become
greatly expanded. In contrast, the label in the perichondrium
has become elongated parallel to the long axis of the bone
rudiment, and its initial organization into a network is no
longer distinct. The intensity of the label in the perichondri-
um is also brighter than it is in the diaphysis. Together, these
differences suggest that whereas in the cartilage matrix there
has been an expansion of the injected collagen, in the peri-
chondrium there has been an accumulation of label in a pre-
ferred orientation. The interpretation that growth of the car-
tilage matrix produces expansion of the label is confirmed
when the injection site is found in epiphyseal cartilage or still
differentiating cartilage near joints (Fig. 3B). In these carti-
lage matrices, which have undergone little growth, the ex-
pansion of the label occurred to a much lesser extent than in
the diaphyses.
The most dramatic rearrangements were observed when
FIG. 2. (A) Labeled collagen is found in both the perichondrium (arrowheads) and the cartilage matrix (arrows) of the humerus and is viewed
with combined phase-contrast and fluorescence optics. Initial distribution of injected collagen was comparable to that shown in Fig. 1B.
Embryo was fixed at stage 30. (Bar = 100 ,m.) (B) Labeled collagen is located in the prospective tendon region of the ventral flexors with the
ulna (ul) visible to the right. In previous sections, the ulna extended across the field, but in this section only its proximal portion remains.
Muscle mass of the ventral flexors is out of the field of view to the left. The strands of fluorescent collagen have a wavy form (arrow) and extend
in and out of the plane of focus. Embryo survived until stage 31 (7 days). (Bar = 50 gum.) (C) Biceps muscle (bi) and humerus are shown in a
combined fluorescent and phase-contrast view. Inside the muscle, the labeled collagen (arrowheads) is divided into numerous irregular strands.
In the external fascia of the muscle (perimysium) and as it approaches the perichondrium (fp), the label (arrows) is organized into parallel
elongated strands. Embryo survived to stage 30 (6.5 days). (Bar = 100 pm.) (D) Labeled collagen was accumulated onto the outer wall of blood
vessels. Fluorescence intensity of the label is greater in the blood vessel wall than in the adjacent loose mesenchyme where it is not organized
into any particular pattern. Embryo survived to stage 34 (8 days). (Bar = 50 pm.)
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FIG. 3. (A) Injected collagen is located between the humerus (hu) and the biceps muscle (bi), partially in the perichondrium (fp), and
partially in the perimysium. This is the same embryo shown in Fig. 2C viewed with combined fluorescence and phase-contrast optics. Embryo
was fixed at stage 30. (Bar = 100 Aum.) (B) Scapula (sc) is cut transversely and viewed with combined phase-contrast and fluorescence optics. In
cartilage, which had undergone a small amount of growth, rearrangement of the labeled collagen was minimal with perhaps a slight expansion of
this material. Embryo survived to stage 31 (7 days). (Bar = 50 um.) (C) Perichondrium of the humerus (hu) and the loose mesenchyme
surrounding it contains fluorescent collagen. Moving from the epithelium (ep) to the humerus, the injected collagen becomes progressively
more rearranged as the humerus is approached. In the fibrous perichondrium (fp), the label is highly elongated, broken up into strands, and has
a bright intensity. Viewed with fluorescence optics. Embryo survived to stage 35 (8-9 days). (Bar = 100 atm.) (D) Labeled collagen was
distributed onto the surface of the perineurium. This fluorescence micrograph is from the same embryo shown in Fig. 2A. Rather than a network
of strands, the label here has been incorporated into the connective tissue sheath wrapping the nerve (n). (Bar = 50 jam.)
the injection site was located just outside the shaft of a devel-
oping long bone. In these regions, the labeled collagen be-
came highly elongated parallel to the long axis of the bone
rudiment and compressed in the transverse direction (Figs. 2
A-C and 3 A and C). Fluorescent collagen was often found
in a continuous distribution, which included the perichondri-
um, the connective tissue adjoining it, and sometimes the
muscles or cartilage as well. The outer layer of the perichon-
drium or "fibrous perichondrium" (29) is made up of several
layers of longitudinally oriented fibroblasts that form a liga-
ment-like structure ensheathing the shaft of the long bones.
In both the fibrous perichondrium and the connective tissue
that grades into it, the labeled collagen was broken up into a
series of long parallel strands and thicker elongate patches
(Fig. 3 A and C). When viewed horizontally in a grazing sec-
tion of the perichondrium, the labeled collagen was seen to
be organized as a sheet (not shown). In one embryo, an un-
usually large amount of collagen was injected (-3 gl). Label
was found in a continuous mass between the humerus and
the posterior margin of the limb, and both the perichondrium
and the loose mesenchyme surrounding it contained labeled
collagen (Fig. 3C). In the perichondrium, the fluorescent
collagen was highly elongated and arranged as strands, while
in the mesenchyme furthest away from the humerus (not
shown) the label appeared to be unaltered, similar to what is
shown in Fig. 1C. Similarly, in regions of prospective ten-
dons and the fascia, which cover the muscles, the label was
organized into elongate patches and thinner strands running
parallel to the long axes of the cells (Fig. 2B). These strands
of fluorescent collagen were not straight but were undulating
and wavy, often extending in and out of the plane of focus.
In muscle, the labeled collagen was broken up into smaller
irregular patches (Fig. 2C) or into finer strands that were
scattered within the muscle tissue. The label did not form a
regular pattern inside the muscle itself but seemed to be in-
terdigitated within it; in the perimysium, the label was highly
elongated as it graded into the perichondrium. Why so few
embryos (only two) were found with label contained inside
muscles is not clear.
Fluorescent strands of collagen were found incorporated
within the walls of blood vessels. In two embryos, the label
formed a complete circle around the outer vessel walls and
appeared to be accumulated at the surface (Fig. 2D). Label
also was rearranged onto the surface of the perineurium,
which is the connective tissue sheath that wraps the nerves
(Fig. 3D).
DISCUSSION
These observations indicate that, separate from the secre-
tion or self-assembly of matrix components, forces exist
within embryonic tissues whose effect is to rearrange extra-
cellular matrices into anatomical patterns. In principle, the
physical cause of these morphogenetic forces might be either
simple growth (30, 31) or cellular traction or some combina-
tion of the two. Growth of the limb is predominantly in the
long direction; however, it is not known what amount of
stress, if any, this growth actually places on mesenchymal
tissues. In general, the mechanical effect of growth will be
opposite that of traction. Because of the increase in volume,
either from cell proliferation or the secretion of extracellular
components, the consequence of growth is to produce ex-
pansion. In contrast, the consequence of traction is com-
pression as well as tension. In different mesenchymal tissues
of the limb, the fluorescent collagen became arranged into
patterns that were distinct from each other. These patterns
were consistent with the predicted effects of cellular traction
combined with expansion due to growth. Furthermore, the
organization of the injected collagen corresponded well with
the patterns of staining observed when antibodies to type I
collagen are used to detect the distribution of collagen in the
developing limb (27, 28, 32).
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From our previous studies, several predictions can be
made as to how cell traction may operate to help construct
connective tissues during morphogenesis (4-7). Where cell
traction is weak, the extracellular matrix will remain uncon-
densed, and loose connective tissues will form. This could
explain the inability of cells in loose mesenchyme to remodel
a cohesive mass of injected collagen. Chondrocytes in vitro
are not able to contract collagen gels (17) so rearrangement
of the injected collagen in cartilage should, primarily, be due
to growth, as was observed. Inside the diaphysis of cartilage,
the label became more diffuse as if being spread apart by
growth, while in epiphyseal cartilage, which grows less, this
expansion was less pronounced or absent (Figs. 2A and 3B).
In this context, it is of interest that, although cartilage syn-
thesizes type II collagen, the presence of the injected type I
collagen did not interfere with normal morphogenesis.
Where strong traction is exerted by a population of cells
and is not resisted by countervailing tension, compressive
strains will predominate. Collagen and other extracellular fi-
bers will be drawn toward the cells and compacted to form
dense irregular connective tissues. Fluorescent collagen was
wrapped as a dense sheet applied to the outer surfaces of
perichondria, perineuria, and blood vessels, as predicted.
Endothelial cells, which make up the walls of blood vessels,
and fibroblasts, which make up the connective tissue sheath
of the perineurium and perichondrium, are all capable of ex-
erting strong tractional forces (5, 12).
Dense regular connective tissues, as in tendons and liga-
ments, will form where resistance to the forces exerted by
cells causes tensile strains to develop in one direction (5). In
the embryo, where cells become aligned parallel to one an-
other, their traction will generate tension in the direction of
cell elongation, causing fibers to be aligned parallel to one
another. In tendons as well as in the fibrous perichondria,
the fluorescent collagen either was organized into highly
elongate patches or was broken up into more narrow parallel
strands. A consistent feature of these strands was their wavy
appearance (Fig. 2B). Later in development, collagen fibers
in tendons develop sharp undulations with a characteristic
period (33). The less extreme bending of the fluorescent col-
lagen observed here may be antecedent to the development
of the mature crimp morphology.
An unavoidable limitation of this technique is that alter-
ations in the distribution and arrangement of the labeled col-
lagen must be inferred from fixed tissue, raising the possibili-
ty that the collagen was injected in a form that was then mis-
taken for rearrangement. However, the pattern of labeling
found later in development did not correspond to the pat-
terns observed immediately after injection. In many embry-
os, more than one kind of tissue in the same embryo con-
tained labeled collagen. But as development progressed, col-
lagen from the same injection site became arranged
appropriately for the tissue type where it happened to be-
come localized. Since the collagen was injected before dif-
ferentiated structures had yet emerged, this implies that the
physical environment attending develoment is distinct from
one tissue to another.
We suggest that the organization of collagen within tissues
is due to the combined effect of short-range and long-range
interactions. Previous studies on collagen morphogenesis
have placed the greatest, if not sole, emphasis on the short-
range ordering of collagen and, in particular, self-assembly
(1, 2). Collagen molecules do possess a remarkable capacity
for self-assembly into fibrils, and such findings have lent
support to the expectation that collagen morphogenesis
could be explained in terms of self-assembly and its modula-
tion by the chemical environment. Another possibility is that
motile cells secrete fibers into place by using specialized
extracellular spaces to deposit the collagen in ordered arrays
(34). However, by confronting the embryo with preformed
collagen fibrils from another species, these experiments
were designed to bypass these kinds of short-range interac-
tions. We conclude that there exists within embryos mecha-
nisms for the long-range ordering of collagen, apparently de-
termined by the physical environment of mechanical stresses
and strains, including those generated by cell traction.
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